|
시장보고서
상품코드
2032625
옵토제네틱스 시장 보고서 : 조명 기기 유형, 용도, 최종 사용자, 지역별(2026-2034년)Optogenetics Market Report by Light Equipment Type (Light-emitting Diode, Laser), Application, End User, and Region 2026-2034 |
||||||
세계의 옵토제네틱스 시장 규모는 2025년에 586억 달러에 달했습니다. 향후, IMARC Group은 2034년까지 시장 규모가 1,811억 달러에 이르고, 2026-2034년 CAGR은 12.95%를 나타낼 것으로 예측했습니다. 이 시장의 주요 성장 요인으로는 옵토제네틱스 기술의 눈부신 발전, 신경질환 발병률 증가, 정밀의료에 대한 수요 증가, 공공 및 민간 기관의 연구개발 활동에 대한 막대한 투자 등을 들 수 있습니다.
옵토제네틱스는 유전학과 광학 기술을 결합한 과학적 접근법을 말합니다. 주로 광센서를 사용하여 뉴런 및 기타 세포의 생물학적 기능을 제어하고 모니터링하는 데 사용됩니다. 이 정보는 운동, 학습, 기억, 내비게이션, 신진대사, 호흡, 감각처리 등 개인의 행동과 생리적 기능에 대한 지식을 제공합니다. 옵토제네틱스는 만성통증, 간질, 파킨슨병, 뇌졸중, 약물중독, 강박장애(OCD), 사회기능장애, 불안, 우울증 등 다양한 질환과 관련된 세포 활동을 규명하여 임상적 발견에 기여하고 있습니다. 이러한 응용 분야로 인해 옵토제네틱스는 신경과학 분야에서 폭넓게 활용되고 있습니다.
옵토제네틱스 시장 동향 :
다양한 감염, 질병, 유전성 질환, 선천성 기형 및 뇌, 신경, 척수 손상으로 인한 신경 질환의 유병률 증가는 현재 옵토제네틱스 시장의 성장을 주도하는 주요 요인 중 하나입니다. 이에 따라 임플란트에 내장되어 유선 연결이 필요 없는 광전송을 가능하게 하는 광섬유 결합형 발광다이오드(LED)의 도입도 또 다른 주요 성장 촉진요인으로 작용하고 있습니다. 또한, 신경 연결, 무선 마이크로칩, 센서, 세포 표현형 분석 도구, 컴퓨터 단층촬영(CT), 양전자방출단층촬영(PET), 자기공명영상(MRI) 등 다양한 영상 진단 도구의 급속한 기술 발전으로 장기 및 조직을 정밀하게 평가하고 질병을 식별할 수 있게 됨에 따라 할 수 있게 되었으며, 이는 시장 성장을 견인하고 있습니다. 또한, 세포 수준, 공간적, 시간적 정확도가 높아지면서 의료진들이 옵토제네틱스 치료법을 채택하는 경향이 높아진 것도 시장 성장에 기여하고 있습니다. 또한, 헬스케어 분야의 의료비 증가, 신경과학 분야의 광범위한 연구개발(R&D) 활동, 주요 기업, 제약사 및 정부 간의 전략적 제휴를 통해 신경질환 치료 신약 출시를 지원하는 유리한 정책을 시행하는 등 다양한 요인들이 긍정적인 시장 전망을 제시하고 있습니다. 을 창출하고 있습니다.
경쟁 구도 :
본 산업 경쟁 구도와 관련하여, 주요 기업 프로파일로는 Addgene, Coherent Inc. Laserglow Technologies, Noldus Information Technology, Regenxbio Inc, Shanghai Laser &Optics Century Co. Inc.가 검증되었습니다.
본 보고서에서 답변을 얻을 수 있는 주요 질문
1. 2025년 세계의 옵토제네틱스 시장 규모는 어느 정도였습니까?
2. 2026년부터 2034년까지 세계 옵토제네틱스 시장의 예상 성장률은?
3. 세계의 옵토제네틱스 시장을 이끄는 주요 요인은?
4. 코로나19는 세계의 옵토제네틱스 시장에 어떤 영향을 미쳤는가?
5.조명기기 유형별로 볼 때, 세계의 옵토제네틱스 시장 내역은 어떤 모습일까요?
6. 세계 광유전체 시장의 용도별 시장 현황은?
7. 세계 옵토제네틱스 시장의 주요 지역은?
8. 세계 옵토제네틱스 시장의 주요 기업은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 옵토제네틱스 시장
제6장 시장 분석 : 조명 기기 유형별
제7장 시장 분석 : 용도별
제8장 시장 분석 : 최종 사용자별
제9장 시장 분석 : 지역별
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KTH 26.05.20The global optogenetics market size reached USD 58.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 181.1 Billion by 2034, exhibiting a growth rate (CAGR) of 12.95% during 2026-2034. The market is primarily driven by the notable developments in optogenetics technology, rising incidence of neurological illnesses, growing need for precision medicine, and substantial investment by public and private organizations in research and development activities.
Optogenetics refers to a scientific approach that includes a combination of genetics and optics technologies. It is primarily used for controlling and monitoring the biological functions of neurons and other types of cells with light sensors. This information provides insights into individual behavior and physiology, including movement, learning, memory, navigation, metabolism, respiration, and sensor processing. Optogenetics aids in clinical discoveries by shedding light on the cellular activities associated with various diseases, such as chronic pain, epilepsy, Parkinson disease, stroke, drug addiction, obsessive compulsion disorder (OCD), social dysfunction, and anxiety and depression. On account of these applications, optogenetics finds extensive utilization in the field of neurosciences.
Optogenetics Market Trends:
The increasing prevalence of neurological disorders due to various infections, ailments, genetic disorders, congenital abnormalities, and brain, nerve, and spinal cord injuries is one of the key factors currently driving the optogenetics market growth. In line with this, the introduction of fiber-coupled light-emitting diode (LED) for being incorporated into the implants to enable the untethered light delivery is acting as another major growth-inducing factor. Additionally, rapid technological advancements in neural connectivity, wireless microchip, sensors, cell phenotyping tools, and various imaging tools, like computed tomography (CT), position emission tomography (PET), and magnetic resonance imaging (MRI) to precisely evaluate organs and tissues for identifying disorders is propelling the market growth. The rising inclination of healthcare professionals toward optogenetic therapeutic methodologies on account of its cellular, spatial, and temporal precision is further contributing to the market growth. Other factors, including increasing healthcare expenditure, extensive research and development (R&D) activities in the field of neurosciences, and strategic collaborations between key players, pharmaceutical companies, and governments of various nations to implement favorable policies that support the launch of novel drugs for treating neurological diseases, are creating a positive outlook for the market.
Market Segmentation:
This report provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2026-2034. The report categorizes the market based on light equipment type, application and end user.
Breakup by Light Equipment Type:
- Light-emitting Diode (LED)
- Laser
Breakup by Application:
- Neuroscience
- Behavioral Tracking
- Retinal Disease Treatment
- Others
Breakup by End User:
- Hospitals
- Clinics
- Diagnostic
- Research
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Addgene, Coherent Inc., Elliot Scientific Limited, GenSight Biologics S.A., HUBNER GmbH & Co KG, Judges Scientific plc, Laserglow Technologies, Noldus Information Technology, Regenxbio Inc., Shanghai Laser & Optics Century Co. Ltd, The Jackson Laboratory and Thorlabs Inc.
Key Questions Answered in This Report
1. What was the size of the global optogenetics market in 2025?
2. What is the expected growth rate of the global optogenetics market during 2026-2034?
3. What are the key factors driving the global optogenetics market?
4. What has been the impact of COVID-19 on the global optogenetics market?
5. What is the breakup of the global optogenetics market based on the light equipment type?
6. What is the breakup of the global optogenetics market based on the application?
7. What are the key regions in the global optogenetics market?
8. Who are the key players/companies in the global optogenetics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Optogenetics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Light Equipment Type
- 6.1 Light-emitting Diode (LED)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Laser
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Application
- 7.1 Neuroscience
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Behavioral Tracking
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Retinal Disease Treatment
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Diagnostic
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Research
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Addgene
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Coherent Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Elliot Scientific Limited
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 GenSight Biologics S.A.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.5 HUBNER GmbH & Co KG
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Judges Scientific plc
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.7 Laserglow Technologies
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Noldus Information Technology
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Regenxbio Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Shanghai Laser & Optics Century Co. Ltd
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 The Jackson Laboratory
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.12 Thorlabs Inc.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.1 Addgene
